Intended use:

For in vitro diagnostic use. This test is an enzyme linked immunoassay intended for the quantitative determination of infliximab (IFX, Remicade®) and the biosimilars Remsima® und Inflectra® in human serum und plasma.

General Information:

The lateral flow assay RIDA®QUICK IFX Monitoring is a rapid point-of-care assay, which allows for the quantitative determination of infliximab trough levels (TLs) within 20 minutes. It facilitates the use of therapeutic drug monitoring in hospitals and infusion centers and the decision making in regards to therapy adaptation.

  • Fast and reliable drug monitoring of infliximab and its biosimilars (Remsima® & Inflectra®)
  • Quantitative lateral flow test
  • 20 minutes time to result
  • High correlation to RIDASCREEN® IFX Monitoring due to identical monoclonal antibody (MA-IFXB7)
  • 25 test cassettes per package
  • 2 controls available as accessory

Accessories:

Specifications
Art. No. GN3041
Files
InstructionsGerman
English
French
Spanish
Italian
SDSgn3041_english.zip (English)
gn3041_german.zip (German)
gn3041_french.zip (French)
gn3041_italian.zip (Italian)
gn3041_spanish.zip (Spanish)
Similar Products
RIDA®QUICK Helicobacter
RIDA®QUICK Helicobacter
For in vitro diagnostic use. RIDA®QUICK Helicobacter is an immunochromatographic rapid test (ICT) for the qualitative detection of Helicobacter pyl...
RIDA®QUICK ADM Monitoring
RIDA®QUICK ADM Monitoring
For in-vitro diagnostics. This test is a lateral flow immunochromatographic assay for the quantitative detection of adalimumab (ADM, Humira®) in hu...
RIDA®TUBE
RIDA®TUBE
For in-vitro diagnostics. Stool collection tubes (without buffer) for the stool sample taking and extraction in laboratories.

Start typing and press Enter to search

gz3012_rida-tube-haemoglobin_tube-boxrida-quick-ifx-monitoring-control-set